Jian Yu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Oncogene

Communications biology

Molecular biomedicine

Molecular carcinogenesis

University of Pittsburgh

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh

United States

Full Professor :: Pathology

University of Pittsburgh

United States

Associate Professor :: Pathology

University of Pittsburgh

United States

Assistant Professor :: Pathology

Johns Hopkins School of Medicine

United States

Postdoctoral Fellow :: Oncology

University of Southern California

United States

Research Technician II :: Biology

Education History

Johns Hopkins University

United States

PHD :: Human Genetics and Molecular Biology

Sichuan University

China

BSC :: Chemistry

Publications

Bogdan Kochetov, Phoenix D Bell, Paulo S Garcia, Akram S Shalaby, Rebecca Raphael, Benjamin Raymond, Brian J Leibowitz, Karen Schoedel, Rhonda M Brand, Randall E Brand, Jian Yu, Lin Zhang, Brenda Diergaarde, Robert E Schoen, Aatur Singhi, Shikhar Uttam
UNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples. Communications biology 7 (1) (2024)
Bogdan Kochetov, Phoenix D Bell, Paulo S Garcia, Akram S Shalaby, Rebecca Raphael, Benjamin Raymond, Brian J Leibowitz, Karen Schoedel, Rhonda M Brand, Randall E Brand, Jian Yu, Lin Zhang, Brenda Diergaarde, Robert E Schoen, Aatur Singhi, Shikhar Uttam
UNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples. Communications biology 7 (1) (2024)
Jingshan Tong, Xiao Tan, Suisui Hao, Kaylee Ermine, Xinyan Lu, Zhaojin Liu, Anupma Jha, Jian Yu, Lin Zhang
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene 42 (12) (2023)
Jingshan Tong, Xiao Tan, Suisui Hao, Kaylee Ermine, Xinyan Lu, Zhaojin Liu, Anupma Jha, Jian Yu, Lin Zhang
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene (2023)
Jingshan Tong, Xiao Tan, Suisui Hao, Kaylee Ermine, Xinyan Lu, Zhaojin Liu, Anupma Jha, Jian Yu, Lin Zhang
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene (2023)
Jingshan Tong, Xiao Tan, Suisui Hao, Kaylee Ermine, Xinyan Lu, Zhaojin Liu, Anupma Jha, Jian Yu, Lin Zhang
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene 42 (12) (2023)
Dongshi Chen, Kaylee Ermine, Yi-Jun Wang, Xiaojun Chen, Xinyan Lu, Peng Wang, Donna Beer Stolz, Jian Yu, Lin Zhang
PUMA/RIP3 mediates chemotherapy response via necroptosis and local immune activation in colorectal cancer. Molecular cancer therapeutics (2023)
Jingshan Tong, Xiao Tan, Suisui Hao, Kaylee Ermine, Xinyan Lu, Zhaojin Liu, Anupma Jha, Jian Yu, Lin Zhang
Inhibition of multiple CDKs potentiates colon cancer chemotherapy via p73-mediated DR5 induction. Oncogene 42 (12) (2023)
Jingshan Tong, Xiao Tan, Xiangping Song, Man Gao, Denise Risnik, Suisui Hao, Kaylee Ermine, Peng Wang, Hua Li, Yi Huang, Jian Yu, Lin Zhang
CDK4/6 Inhibition Suppresses p73 Phosphorylation and Activates DR5 to Potentiate Chemotherapy and Immune Checkpoint Blockade. Cancer research 82 (7) (2022)
Alexis Espinal, Michael W Epperly, Amitava Mukherjee, Renee Fisher, Donna Shields, Hong Wang, M Saiful Huq, Diala Fatima Hamade, Anda M Vlad, Lan Coffman, Ronald Buckanovich, Jian Yu, Brian J Leibowitz, Jan-Peter van Pijkeren, Ravi B Patel, Donna Stolz, Simon Watkins, Asim Ejaz, Joel S Greenberger
Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22. International journal of molecular sciences 23 (10) (2022)
Hang Ruan, Brian J Leibowitz, Yingpeng Peng, Lin Shen, Lujia Chen, Charlie Kuang, Robert E Schoen, Xinghua Lu, Lin Zhang, Jian Yu
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer. Molecular biomedicine 3 (1) (2022)
Brian J Leibowitz, Guangyi Zhao, Liang Wei, Hang Ruan, Michael W Epperly, Lujia Chen, Xinghua Lu, Joel S Greenberger, Lin Zhang, Jian Yu
Interferon b drives intestinal regeneration after radiation. Science advances 7 (41) (2021)
Jingshan Tong, Xiao Tan, Denise Risnik, Man Gao, Xiangping Song, Kaylee Ermine, Liangfang Shen, Shaomeng Wang, Jian Yu, Lin Zhang
BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade. Oncogene 40 (48) (2021)
Rochelle Fletcher, Jingshan Tong, Denise Risnik, Brian J Leibowitz, Yi-Jun Wang, Fernando Concha-Benavente, Jonathan M DeLiberty, Donna B Stolz, Reet K Pai, Robert L Ferris, Robert E Schoen, Jian Yu, Lin Zhang
Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene 40 (11) (2021)
Yini Dang, Yifeng Zhang, Lingyan Xu, Xiaoying Zhou, Yanhong Gu, Jian Yu, Shidai Jin, Haoming Ji, Yongqian Shu, Guoxin Zhang, Shiyun Cui, Jing Sun
PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis. Cell death & disease 11 (2) (2020)
Hang Ruan, Brian J Leibowitz, Lin Zhang, Jian Yu
Immunogenic cell death in colon cancer prevention and therapy. Molecular carcinogenesis 59 (7) (2020)
Hang Ruan, Xiangyun Li, Xiang Xu, Brian J Leibowitz, Jingshan Tong, Lujia Chen, Luoquan Ao, Wei Xing, Jianhua Luo, Yanping Yu, Robert E Schoen, Nahum Sonenberg, Xinghua Lu, Lin Zhang, Jian Yu
eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis. eLife 9 (2020)
Brian J Leibowitz, Liheng Yang, Liang Wei, Monica E Buchanan, Madani Rachid, Robert A Parise, Jan H Beumer, Julie L Eiseman, Robert E Schoen, Lin Zhang, Jian Yu
Targeting p53-dependent stem cell loss for intestinal chemoprotection. Science translational medicine 10 (427) (2019)

Jian Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jian Yu